Home › Funds › Champlain Investment Partners, LLC › EW

Champlain Investment Partners, LLC position in EW

EDWARDS LIFESCIENCES CORP · Health Care

Champlain Investment Partners, LLC reported holding 292,945 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$25.3M, representing 0.87% of its reported portfolio and ranking #46 among its reported holdings. Champlain Investment Partners, LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)292.94K sh
Reported value held$25.29M
Portfolio Weight0.87%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Champlain Investment Partners, LLC's EW position evolved

Champlain Investment Partners, LLC first disclosed a stake in EW in Q3 2023 at 2,767,323 shares (US$191.7M). The position peaked in Q1 2024 at 2,964,168 shares, worth US$283.3M. Across 13 filings, Champlain Investment Partners, LLC increased the stake 3 time(s), trimmed it 9 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 292,945 shares valued at US$25.3M — a reduction of -53,695 shares quarter over quarter.. Notable position changes include a 40% trim in Q1 2026 (shares rose 13% over the following quarter), a 66% trim in Q2 2026 (shares fell 5% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.77M $191.72M New
Q4 2023 2.88M $219.29M Add
Q1 2024 2.96M $283.26M Add
Q2 2024 2.95M $272.32M Reduce
Q3 2024 3.08M $203.30M Add
Q4 2024 2.82M $208.89M Reduce
Q1 2025 2.61M $189.30M Reduce
Q2 2025 2.22M $173.92M Reduce
Q3 2025 2.11M $164.45M Reduce
Q4 2025 1.73M $147.84M Reduce
Q1 2026 1.03M $82.76M Reduce
Q2 2026 346.64K $31.36M Reduce
Q3 2026 292.94K $25.29M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has Champlain Investment Partners, LLC held EW?

Champlain Investment Partners, LLC has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Champlain Investment Partners, LLC's current position in EW?

As of Q3 2026, Champlain Investment Partners, LLC holds 292.94K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $25.29M, representing 0.87% of its reported portfolio and ranking #46.

Has Champlain Investment Partners, LLC been buying or selling EW?

In the latest 13F filing (Q3 2026), Champlain Investment Partners, LLC reduced its position in EW. The position peaked in Q1 2024 at 2.96M shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.